Analysis reveals how sample size and learning algorithm influence cross-validation error, suggesting a fundamental trade-off in risk estimation accuracy.
Despite ongoing theoretical research on cross-validation (CV), many theoretical questions about CV remain widely open. This motivates our investigation into how properties of algorithm-distribution pairs can affect the choice for the number of folds in k-fold cross-validation. Our results consist of a novel decomposition of the mean-squared error of cross-validation for risk estimation, which explicitly captures the correlations of error estimates across overlapping folds and includes a novel algorithmic stability notion, squared loss stability, that is considerably weaker than the typically required hypothesis stability in other comparable works. Furthermore, we prove: 1. For every learning algorithm that minimizes empirical error, a minimax lower bound on the mean-squared error of k-fold CV estimating the population risk LD: \[ mink n\; maxD\; E\![({L}CV⁽ᵏ⁾ - LD)²] \;=\; Ω\!(√k/n), \] where n is the sample size and k the number of folds. This shows that even under idealized conditions, for large values of k, CV cannot attain the optimum of order $1/n$ achievable by a validation set of size n, reflecting an inherent penalty caused by dependence between folds. 2. Complementing this, we exhibit learning rules for which \[ maxD\; E\![({L}CV⁽ᵏ⁾ - LD)²] \;=\; Ω(k/n), \] matching (up to constants) the accuracy of a hold-out estimator of a single fold of size $n/k$. Together these results delineate the fundamental trade-off in resampling-based risk estimation: CV cannot fully exploit all n samples for unbiased risk evaluation, and its minimax performance is pinned between the $k/n$ and √k/n regimes.
No takes yet. Share an insight, caveat, or question.
Nachum et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: